Phenobarbital Tablet — FDA Drug Shortage

To Be Discontinued — Endo Pharmaceuticals, Inc.

The FDA lists a drug shortage record for Phenobarbital Tablet (tablet) from Endo Pharmaceuticals, Inc. with status To Be Discontinued. The shortage was first posted on 10/31/2025.

Shortage Details

Status
To Be Discontinued
Company
Endo Pharmaceuticals, Inc.
Package NDC
0603-5168-21
Dosage Form
Tablet
Presentation
Phenobarbital, Tablet, 97.2 mg (NDC 0603-5168-21)
Initial Posting
10/31/2025
Revised Date